12 Health Care Stocks Moving In Friday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Friday's pre-market session, several healthcare stocks experienced significant movements. Heart Test Laboratories, Virpax Pharmaceuticals, NuCana, Arcutis Biotherapeutics, Verrica Pharmaceuticals, and C4 Therapeutics saw their stocks rise, with increases ranging from 12.17% to 27.1%. Conversely, Aadi Bioscience, Aileron Therapeutics, Envoy Medical, Palatin Techs, Assure Holdings, and RenovoRx faced declines between 8.18% and 44.3%.
December 15, 2023 | 1:08 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Arcutis Biotherapeutics' shares increased by 13.77% to $2.89, with a market cap of $272.7 million.
The notable pre-market increase could suggest a bullish trend for the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
C4 Therapeutics' shares increased by 12.17% to $5.62, with a market cap of $276.9 million.
The positive movement in pre-market trading could indicate a short-term bullish trend for the stock.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Heart Test Laboratories' stock rose 27.1% to $0.2, with a market cap of $9.7 million.
The significant pre-market rise in stock price indicates strong investor interest, which could lead to continued short-term upward momentum.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
NuCana's stock rose 14.11% to $0.4, with a market cap of $21.0 million.
The pre-market rise could attract investor attention, potentially leading to a short-term positive trend.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Verrica Pharmaceuticals' shares rose by 12.5% to $4.23, with a market cap of $177.9 million.
The pre-market gain is a positive signal that could lead to further short-term appreciation.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Virpax Pharmaceuticals' stock increased by 25.77% to $0.3, with a market cap of $3.5 million.
The substantial pre-market increase suggests positive sentiment that could drive further short-term gains.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Aadi Bioscience shares declined by 44.3% to $2.99, with a market cap of $73.3 million.
The sharp decline in pre-market could indicate significant negative sentiment, likely leading to further short-term downside.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
Aileron Therapeutics shares fell 15.83% to $4.52, with a market cap of $22.0 million.
The pre-market drop may reflect investor concerns, potentially leading to a continued downward trend in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Envoy Medical stock decreased by 13.13% to $1.92, with a market cap of $37.5 million.
The decline in pre-market suggests bearish investor sentiment that may continue in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Assure Holdings stock fell 8.64% to $0.34, with a market cap of $2.2 million.
The drop in pre-market trading may indicate a negative outlook, which could persist in the short term.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
Palatin Techs stock declined by 11.74% to $2.33, with a market cap of $32.0 million.
The pre-market decline could be a sign of negative market sentiment, possibly leading to further short-term losses.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
RenovoRx shares declined by 8.18% to $0.88, with a market value of $9.4 million.
The negative pre-market movement could suggest a bearish trend for the stock in the short term.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100